Nomura Holdings’s GeneDx Holdings WGS Stock Holding History

Nomura Holdings’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,586	Closed	-$1.41M	–	2461
2021 Q4	$1.41M	Hold	9,586	–	–	﹤0.01%	1111
2021 Q3	$2.41M	Buy	+9,586	New	+$3.29M	0.01%	855

Other funds holding WGS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Nomura Holdings's WGS Position: Q1 2022 in Review

Nomura Holdings sold out of GeneDx Holdings (WGS) in Q1 2022, closing a stake of 9,586 shares — an estimated $1.41M sold.

Nomura Holdings first reported a position in WGS in Q3 2021 and held it in 2 quarters. The position peaked at $2.41M in Q3 2021. 108 funds tracked by Wall St. Rank hold WGS as of Q1 2022.

Nomura Holdings reported no remaining GeneDx Holdings position as of Q1 2022 after selling out during the quarter.
Nomura Holdings sold 9,586 GeneDx Holdings shares in Q1 2022, an estimated $1.41M.
Nomura Holdings first reported a position in GeneDx Holdings in Q3 2021 and held it in 2 quarters.
Nomura Holdings's GeneDx Holdings position peaked at $2.41M in Q3 2021.
108 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.